Mutations in the SOD1 gene account for about 15% of familial #ALS. When people living with ALS, like Mark Buermann, enroll in clinical trials, they help researchers learn more about the underlying causes of the disease which can help them develop new treatments. Learn more if you're interested in enrolling in a clinical trial: https://bit.ly/ClinicalTrialsALS | The ALS Association

38K views · 1.9K reactions | @muellerlab at UMass Medical School has developed a #gene transfer approach that could be the future of #ALS #treatment by silencing the mutated SOD1 gene using microRNAs. https://www.umassmed.edu/muellerlab/ | Sci Ani | Facebook